Olympus Corporation Consolidated Financial Results for the 3rd Quarter Fiscal 2024

Stefan Kaufmann
Director, Representative Executive Officer, President and Chief Executive Officer
Chikashi Takeda
Executive Officer and Chief Financial Officer
Frank Drewalowski
Executive Officer and Endoscopic Solutions Division Head
Gabriela Kaynor
Executive Officer and Therapeutic Solutions Division
Boris Shkolnik
Global Head of Quality

PLAY LIST

from the beginning

The Impact of the 2024 Noto Peninsula Earthquake

Executive Officers in FY2025

Key Message

GI Area Driving Sales Growth

TaewoongMedical Acquisition Further Enhances Our Care Pathway Strategy and Leading Position Within GI disease

Consolidated Financial Results for the 3rdQuarter and Full-year Forecasts for Fiscal 2024

01 Consolidated Financial Results and Business Review for the 3Q of Fiscal 2024 (FY Ending March 31, 2024)

3Q of Fiscal 2024 (1) Consolidated Financial Results

02 Forecasts for Fiscal 2024

Fiscal2024Consolidated Forecasts

Fiscal2024Forecastsby Business Segment

Factors that Affect Fiscal 2024 Forecasts (vs. Previous Forecast)

Q&A 1

Q&A 2

Q&A 3

Q&A 4

Q&A 5

Q&A 6

Q&A 7

Q&A 8

Back
Next

Download